Biochemical pharmacology of Gilles de la Tourette's syndrome

Abuzzahab, 1973, Gilles de la Tourette's Syndrome, Int. Reg. Minn. Med., 56, 492 Abuzzahab, 1976, vol. 1 Abuzzahab, 1981, Clonidine HCl in Gilles de la Tourette Syndrome, 17 Ananth, 1982, Impotence associated with pimozide, Am. J. Psychiatry, 139, 10 Anden, 1970, Receptor activity and turnover of dopamine and noradrenaline after neuroleptics, Eur. J. Pharmacol., 11, 303, 10.1016/0014-2999(70)90006-3 Ang, 1982, Reduced excretion of MHPG in Tourette Syndrome, Adv. Neurol., 35, 171 Bachman, 1981, Pimolin-induced Tourette's disorder; A case report, Am. J. Psychiatry, 138, 1116, 10.1176/ajp.138.8.1116 Balthasar, 1957, Ueber das anatomische Substrat der generalisierten Tic-Krankheit (maladie de tics, Gilles de la Tourette)—Entwicklungshemmung des Corpus Striatum, Arch. Psychiatry (Berlin), 195, 531, 10.1007/BF00343129 Barbeau, 1961, Excretion of dopamine in diseases of basal ganglia, Science, 133, 1096, 10.1126/science.133.3465.1706-a Bartholini, 1980, Interaction of striatal dopaminergic, cholinergic and GABAergic neurons: Relation to extrapyramidal function, Trend Pharmacol. Sci., 1, 138, 10.1016/0165-6147(79)90049-X Borison, 1983, Treatment approaches in Gilles de la Tourette Syndrome, Brain Res. Bull., 11, 205, 10.1016/0361-9230(83)90192-2 Borison, 1983, Trazodone and Tourette Syndrome, Neurology, 33, 199 Bourdouresque, 1971, La maladie de Gilles de la Tourette, Rev. Neurol., 125, 306 Brunn, 1982, Clonidine treatment of Tourette Syndrome, Adv. Neurol., 35, 403 Bulat, 1971, Origin of 5-hydroxyindoleacetic acid in the spinal fluid, Science, 173, 738, 10.1126/science.173.3998.738 Butler, 1979, Biogenic amine metabolism in Tourette Syndrome, Ann. Neurol., 6, 37, 10.1002/ana.410060109 Butterworth, 1977, Platelet dopamine uptake in Huntington's Chorea and Gilles de la Tourette's Syndrome: Effect of haloperidol, Can. J. Neurol. Sci., 4, 285, 10.1017/S0317167100025130 Cade, 1949, Lithium salts in the treatment of psychotic existment, Med. J. Aust., 36, 349, 10.5694/j.1326-5377.1949.tb36912.x Caine, 1985, Gilles de la Tourette Syndrome: A review of clinical and research studies and consideration of future directions for investigation, Arch. Neurol., 42, 393, 10.1001/archneur.1985.04060040107024 Caine, 1979, Trial of chlorimipramine and desipramine for Gilles de la Tourette Syndrome, Ann. Neurol., 5, 305, 10.1002/ana.410050316 Caprini, 1961, Un grave sindrome ticcosa guarita con haloperidol, Riv. Sper. Freniat., 85, 191 Carlsson, 1973, Effect of ethanol on the metabolism of brain catecholamines, Psychopharmacolgia, 30, 27, 10.1007/BF00422791 Cederbaum, 1977, Catecholamine receptors on locus coeruleus neurons, Eur. J. Pharmacol., 44, 375, 10.1016/0014-2999(77)90312-0 Chase, 1982, vol 35 Chase, 1970, Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders, Neuropharmacology, 9, 265, 10.1016/0028-3908(70)90075-4 Cohen, 1988, Tourette's Syndrome and tic disorder Cohen, 1980, Clonidine ameliorates Gilles de la Tourette Syndrome, Arch. Gen. Psychiatry, 37, 1350, 10.1001/archpsyc.1980.01780250036004 Cohen, 1978, Chronic multiple tick of Gilles de la Tourette's disease: CSF acid monoamine metabolites after probenecid administration, Arch. Gen. Psychiatry, 35, 245, 10.1001/archpsyc.1978.01770260123015 Cohen, 1974, Biogenic amines in autistic and atypical children, Arch. Gen. Psychiatry, 31, 845, 10.1001/archpsyc.1974.01760180085011 Cohen, 1979, Central biogenic amines metabolism in children with syndrome of chronic multiple tics of Gilles de la Tourette: Norepinephrine, serotonin and dopamine, J. Am. Acad. Child Psychiatry, 18, 320, 10.1016/S0002-7138(09)61046-3 Colvin, 1985, Pimozide: Use in Tourette's Syndrome, Drug Intell. Clin. Pharm., 19, 421, 10.1177/106002808501900602 Comings, 1987, A controlled study of Tourette Syndrome. VII summary: A common genetic disorder causing disinhibition of the limbic system, J. Hum. Genet., 41, 839 Creese, 1976, Butyrophenone influences on the opiate receptor, Eur. J. Pharmacol., 36, 231, 10.1016/0014-2999(76)90277-6 Crosley, 1979, Decreased serotonergic activity in Tourette Syndrome, Ann. Neurol., 5, 596, 10.1002/ana.410050623 Dalan, 1973, Lithium therapy in Huntington's chorea and tardive dyskinesia, Lancet, 1, 107, 10.1016/S0140-6736(73)90510-2 Davidson, 1983, Pharmacologic effects of RO22-1319: A new antipsychotic agent, Psychopharmacology (Berlin), 79, 32, 10.1007/BF00433013 Davis, 1970, Alcohol, amines and alkaloids: A possible biochemical basis for alcohol addition, Science, 167, 1005, 10.1126/science.167.3920.1005 Debray, 1972, L'utilization du pimozide en pedopsychiatrie, Nouv. Press Med., 1, 2917 Denckla, 1976, Tic following methylphenidate administration. A report of 20 cases, JAMA, 235, 1349, 10.1001/jama.235.13.1349 Dewulf, 1941, Etudies anatomo-clinques de syndromes hypercinétiques complexes. Partie 3 (une observation anatomo-clinique de maladie des tics (Gilles de la Tourette), Mschr. Psychiatr. Neurol., 104, 53, 10.1159/000148516 DiGiacomo, 1971, A case of Gilles de la Tourette's Syndrome: Recurrent refractoriness to haloperidal and unsuccessful treatment with L-dopa, J. Nerv. Ment. Dis., 152, 115, 10.1097/00005053-197102000-00004 Dorsey, 1982, Clonidine and Gilles de la Tourette Syndrome, Arch. Gen. Psychiatry, 38, 1185, 10.1001/archpsyc.1981.01780350119017 Dugas, 1985, Le syndrome de Gilles de la Tourette: Etat actuel de la maladie des tics, Presse Med., 14, 589 Dysken, 1980, Clondine in Tourette Syndrome, Lancet, 2, 926, 10.1016/S0140-6736(80)92094-2 Ehringer, 1960, Vertiehung Von Noradrealin und dopamine in Gehirn des Menschen and ihr verhalten bei erkrankungen des extrapyramidalen systems, Klin. Wochenschr., 38, 1236, 10.1007/BF01485901 Eldridge, 1977, Gilles de la Tourette's Syndrome, Neurology, 27, 115, 10.1212/WNL.27.2.115 Feinberg, 1979, Effects of dopamine agonists and antagonists in Tourette's disease, Arch. Gen. Psychiatry, 36, 979, 10.1001/archpsyc.1979.01780090065007 Finney, 1981, Deanol and Tourette Syndrome, Lancet, 2, 989, 10.1016/S0140-6736(81)91186-7 Frankel, 1984, Neuro-opthalmic abnormalities in Tourette's syndrome: Functional and anatomic implications, Neurology, 34, 359, 10.1212/WNL.34.3.359 Frankel, 1986, Obsessions and compulsions in Gilles de la Tourette's syndrome, Neurology, 36, 378, 10.1212/WNL.36.3.378 Fras, 1978, Gilles de la Tourette's syndrome: Effects of tricyclic antidepressants, NY State J. Med., 78, 1230 Fras, 1977, The use of methyl phenidate and imipramine in Gilles de la Tourette disease in children, Am. J. Psychiatry, 134, 195, 10.1176/ajp.134.2.195 Freed, 1981, Alcohol-triggered neurolepetic-induced tremor, rigidity and dystonia, Med. J. Aust., 11, 44 Frost, 1983, Clinical uses of lithium salts, Brain Res. Bull., 11, 219, 10.1016/0361-9230(83)90196-X Gadoth, 1987, Naloxone in Gilles de la Tourette's syndrome, Ann. Neurol., 21, 415, 10.1002/ana.410210421 Garelis, 1974, Monoamine metabolites in lumbar CSF: The question of their origin in relation to clinical studies, Brain Res., 79, 1, 10.1016/0006-8993(74)90562-9 Gey, 1964, Einfluss der Dopa Transaminierung auf die Dopa Decarboxylierung in vitro, Experientia, 20, 498, 10.1007/BF02154071 Gilles, 1984, Treatment of multiple tics and the Tourette syndrome, Dev. Med. Child Neurol., 26, 830, 10.1111/j.1469-8749.1984.tb08180.x Gillman, 1986, The endogenous opioid system in Gilles de la Tourette syndrome, Med. Hypotheses, 19, 371, 10.1016/0306-9877(86)90112-X Gillman, 1984, Tourette syndrome: Effect of analgesic concentrations of nitrous oxide and naloxone, Br. Med. J., 288, 114 Goetz, 1984, Fluphenazine and multifocal tic disorders, Arch. Neurol., 41, 271, 10.1001/archneur.1984.04050150049015 Golden, 1988, The use of stimulants in the treatment of Tourette's syndrome, 317 Goldman, 1976, Intention of myoclonus: Successful treatment with clonazepam, Neurology, 26, 24, 10.1212/WNL.26.1.24 Gonce, 1977, Seven cases of Gilles de la Tourette's syndrome: Partial relief with clozapam, a pilot study, Can. J. Neurol. Sci., 4, 279, 10.1017/S0317167100025129 Gross, 1974, A double-blind comparison of once-a-day pimozide, trifluoperazine and placebo in the maintenance care of chronic schizophrenic outpatients, Curr. Ther. Res., 16, 696 Häggendal, 1966, Dopamine in human urine during muscular work, Acta Physiol. Scand., 166, 223, 10.1111/j.1748-1716.1966.tb03188.x Haber, 1986, Gilles de la Tourette's syndrome: A postmorten neuropathological and immunohistochemical study, J. Neurol. Sci., 75, 225, 10.1016/0022-510X(86)90097-3 Hamra, 1983, The remission of tics with lithium therapy: Case report, J. Clin. Psychiatry, 44, 73 Hoge, 1986, A case of Tourette's syndrome with symptoms of attention deficit disorder treatment with desipramine, J. Clin. Psychiatry, 47, 478 Jankovic, 1986, Recent advances in the management of tics, Clin. Neuropharmacol., 9, 100, 10.1097/00002826-198612030-00010 Jankovic, 1984, Effect of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome, Neurology, 34, 688, 10.1212/WNL.34.5.688 Jankovic, 1987, Motor, behavioral and pharmacologic findings in Tourette's syndrome, Can. J. Neurol. Sci., 14, 541, 10.1017/S0317167100038087 Janssen, 1972, An international double blind clinical evaluation of pimozide, J. Clin. pharmacol., 12, 26 Jenner, 1975, Altered 5HT metabolism with clonazepam, diazepam and diphenylhydantoin, J. Pharm. Pharmacol., 27, 707, 10.1111/j.2042-7158.1975.tb09539.x Johannsson, 1974, 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of patients with neurological diseases, Eur. Neurol., 11, 37, 10.1159/000114304 Johnson, 1971, Comparative effects of lithium and chlorpromazine in the treatment of acute manic states, Br. J. Psychiatry, 119, 267, 10.1192/bjp.119.550.267 Joyce, 1979, The effects of morpain applied locally to metencephalic dopamine cell bodies on spontaneous motor activity in the rat, Neurosci. Lett., 14, 207, 10.1016/0304-3940(79)96149-4 Kaim, 1983, A case of Gilles de la Tourette syndrome treated with clonazepam, Brain Res. Bull., 11, 213, 10.1016/0361-9230(83)90194-6 Karki, 1956, The urinary excretion of noradrenaline and adrenaline in different age groups, its diurnal variation and the effect of muscular work on it, Acta Physiol. Scand., 39, 132 Keller, 1973, Increase of 3-methoxy-4-hydroxyphenylethylene glycol in rat brain by neuroleptic drugs, Eur. J. Pharmacol., 23, 183, 10.1016/0014-2999(73)90054-X Kenway, 1973, A double blind comparison of pimozide and haloperidol in the treatment of recurrent anxiety states, Br. J. Clin. Pract., 27, 67, 10.1111/j.1742-1241.1973.tb08974.x Kerbeshian, 1988, Differential responsiveness to lithium in patients with Tourette syndrome, Neurosci. Biobehav. Rev., 12, 233, 10.1016/S0149-7634(88)80052-6 Klempel, 1974, Gilles de la Tourette's symptoms induced by L-dopa, S. Afr. Med. J., 48, 1379 Koslow, 1982, Cerebrospinal fluid monoamine metabolites in Tourette syndrome and their neuroendocrine implications, Adv. Neurol., 35, 185 Kurlan, 1986, Familial Tourette syndrome: Report of a large pedigree and potential for linkage analysis, Neurology, 36, 772, 10.1212/WNL.36.6.772 Lake, 1977, Catecholaine metabolism in Gilles de la Tourette's syndrome, Am. J. Psychiatry, 134, 257, 10.1176/ajp.134.3.257 Lauduron, 1971, Pimozide (Orap): Metabolism and interaction with cerebral amines, Clin. Trials J. Suppl., 2, 19 Lauduron, 1971, Pimozide (Orap): Metabolism and interaction with cerebral amines, Clin. Trials J. Suppl., 2, 78 Lawden, 1986, Gilles de la Tourette syndrome: A review, J. R. Soc. Med., 79, 282, 10.1177/014107688607900508 Logan, 1982, Pimozide: Adverse reaction and prolonged half-life, Br. J. Psychiatry, 140, 433, 10.1192/bjp.140.4.433 Leckman, 1982, Clonidine in the treatment of Tourette syndrome: A review data, Adv. Neurol., 35, 391 Leckman, 1985, Short and long-term treatment of Tourette's syndrome with clonidine: A clinical perspective, Neurology, 35, 343, 10.1212/WNL.35.3.343 L'Hermitte, 1971, Analyse pharmacologique d'un cas de myoclonies d'intention et d'action post-anxiques, Rev. Neurol., 124, 21 Lutz, 1976, Neuroleptic-induced akathisia and dystonia triggered by alcohol, JAMA, 236, 2422, 10.1001/jama.236.21.2422 McKeith, 1981, Clonidine in Tourette syndrome, Lancet, 1, 270, 10.1016/S0140-6736(81)92103-6 Maldosky, 1971, A psychophysiological study of multiple tics, Arch. Gen. Psychiatry, 25, 79, 10.1001/archpsyc.1971.01750130081010 Marikangas, 1979, Blepharospasm: Successful treatment with clonazepam, Neurology, 5, 401 Maas, 1966, A technique for assaying the kinetics of norepinephrine metabolism in the CNS in vivo, Psychosom. Med., 28, 247, 10.1097/00006842-196605000-00005 Matthysse, 1977, The role of dopamine in Schizophrenia, 3 Mattson, 1973, Huntington's chorea and lithium therapy, Lancet, 1, 718, 10.1016/S0140-6736(73)91500-6 Merikangas, 1985, Blood choline and response to clonazepam and haloperidol in Tourette's syndrome, Acta Psychiatr. Scand., 72, 395, 10.1111/j.1600-0447.1985.tb02628.x Messiha, 1974, The relationship of dopamine excretion to chlorpromazine-induced dyskinesia in monkeys, Arch. Int. Pharmacodyn. Ther., 209, 5 Messiha, 1974, A study of biogenic amine metabolites in the cerebrospinal fluid and in urine of monkey with chlorpromazine-induced dyskinesia, J. Neurol. Sci., 21, 39, 10.1016/0022-510X(74)90104-X Messiha, 1980, Biochemical studies after chronic administration of neuroleptics to monkeys, 13 Messiha, 1983, Extrapyramidal disorders: A possible underlying mechanism, Brain Res. Bull., 11, 233, 10.1016/0361-9230(83)90197-1 Messiha, 1988, Tourette's medications: Effect on minor oxidative and reductive pathways of biogenic amines, Neurosci. Biobehav. Rev., 12, 215, 10.1016/S0149-7634(88)80045-9 Messiha, 1970, Dopamine excretion in effective states and following Li2CO3 therapy, Nature, 225, 868, 10.1038/225868a0 Messiha, 1983, Behavioral and clinical profiles of Tourette's disease: A comprehensive overview, Brain Res. Bull., 11, 195, 10.1016/0361-9230(83)90191-0 Messiha, 1976, Lithium carbonate in Gilles de la Tourette's disease, Res. Commun. Chem. Pathol. Pharmacol., 15, 609 Messiha, 1983, Behavioral, metabolic and histological aspects of lithium and ethanol interaction, Drug. Chem. Toxicol., 6, 397, 10.3109/01480548309082718 Messiha, 1972, Effect of peripheral aromatic L-amino acids decarboxylase inhibitor on L-C-14-dopa metabolism in man, Biochem. Pharmacol., 21, 2144, 10.1016/0006-2952(72)90169-4 Messiha, 1971, Haloperidol therapy in Tourette's syndrome: Neurological, biochemical and behavioral correlates, Life Sci., 10, 449, 10.1016/0024-3205(71)90110-X Messiha, 1976, A study of endogenous dopamine metabolism in Gilles de la Tourette's disease, Dis. Nerv. Syst., 37, 470 Messiha, 1977, Biochemical changes associated with drug-produced alterations in motor function and the psyche. A possible underlying mechanism, 20, 297 Messiha, 1980, Cholinergic, anticholinergic agents and hepatic ethanol metabolizing enzymes, Arch. Int. Pharmacodyn. Ther., 248, 4 Messiha, 1974, A psychopharmacological study of catecholamines in affective disorders, J. Nerv. Ment. Dis., 158, 338, 10.1097/00005053-197405000-00005 Messiha, 1983, Modification of mouse liver alcohol and aldehyde dehydrogenase by chlorpromazine, Drug Chem. Toxicol., 6, 409, 10.3109/01480548309014163 Messiha, 1973, Decreased dopamine and homovanillic acid excretion in a case with chlorpromazine-induced Parkinsonism, Res. Commun. Chem. Pathol. Pharmacol., 6, 329 Mesulam, 1986, Cocaine and Tourette's syndrome, N. Engl. J. Med., 315, 398, 10.1056/NEJM198608073150616 Mesulam, 1987, Treatment of Gilles de la Tourette's syndrome: Eight-year, practice-based experience in predominantly adult population, Neurology, 37, 1828, 10.1212/WNL.37.12.1828 Meyerhoff, 1973, Gilles de la Tourette's disease and minimal brain dysfunction: Amphetamine isomers reveal catecholamine correlates in affected patients, Psychopharmacologia, 29, 211, 10.1007/BF00414035 Miller, 1985, Tourette syndrome and drug addiction, Br. J. Psychiatry, 147, 584, 10.1192/bjp.147.5.584 Mitchell, 1980, Gilles de la Tourette's disorders associated with pimoline, Am. J. Psychiatry, 137, 1618, 10.1176/ajp.137.12.1618 Mizumo, 1974, Self-mutilation in Lesch-Nyhan syndrome, Lancet, 1, 761, 10.1016/S0140-6736(74)92990-0 Mondrup, 1985, Progabide in the treatment of hyperkinetic extrapyramidal movement disorders, Acta Neurol. Scand., 72, 341, 10.1111/j.1600-0404.1985.tb00881.x Nyhan, 1972, Clinical features of Lesch-Nyhan syndrome, Arch. Intern. Med., 130, 186, 10.1001/archinte.130.2.186 Papez, 1978, A proposed mechanism of emotion, Arch. Neurol. Psychiatry, 36, 725 Parikh, 1979, Penfluridol in the treatment of Gilles de la Tourette's syndrome, Neurology, 27, 174 Pasinetti, 1984, Dopamine enhances metenkephalin effect from rat striatal slices, Brain Res., 293, 364, 10.1016/0006-8993(84)91244-7 Pauls, 1986, Gilles de la Tourette's syndrome and attention deficit disorder with hyperactivity. Evidence against a genetic relationship, Arch. Gen. Psychiatry, 43, 1177, 10.1001/archpsyc.1986.01800120063012 Pauls, 1986, The inheritance of Gilles de la Tourette's syndrome and associated behavior: Evidence for autosomal dominant transmission, N. Engl. J. Med., 315, 993, 10.1056/NEJM198610163151604 Pauls, 1986, Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship, Arch. Gen. Psychiatry, 43, 1180, 10.1001/archpsyc.1986.01800120066013 Pinder, 1976, Pimozide: A review of its pharmacological properties and therapeutic uses in psychiatry, Drugs, 12, 1, 10.2165/00003495-197612010-00001 Pinta, 1977, Deanol in Gilles de la Tourette syndrome. A preliminary investigation, Dis. Nerv. Syst., 38, 214 Polinsky, 1980, Cholinergic treatment in Tourette syndrome, N. Engl. J. Med., 302, 1310, 10.1056/NEJM198006053022313 Pollack, 1977, Gilles de la Tourette syndrome: Familial occurrence and precipitation by methylphenidate therapy, Arch. Neurol., 34, 630, 10.1001/archneur.1977.00500220064011 Porter, 1971, Aromatic amino acid decarboxylase inhibitors, 30, 871 Prange, 1973, Preliminary experience with tryptophan and lithium in the treatment of tardive dyskinesia, Psychopharmacol. Bull., 9, 36 Reches, 1983, Tetrahenazine, an amine depleting drug, also blocks dopamine receptors in rat brain, J. Pharmacol. Exp. Ther., 225, 515 Regeur, 1986, Clinical features and long-term treatment with pimozide in 65 patient with Gilles de la Tourette's syndrome, J. Neurol. Neurosurg. Psychiatry, 49, 791, 10.1136/jnnp.49.7.791 Richardson, 1982, Neuropathological studies of Tourette syndrome, Adv. Neurol., 35, 83 Rosenbaum, 1980, Tardive dyskinesia in depressed patients: Successful therapy with antidepressants and lithium, Psychosomatics, 21, 715, 10.1016/S0033-3182(80)73616-2 Rosenbaum, 1980, Treatment of tardive dyskinesia in an agitated, depressed patient, Psychosomatics, 21, 765, 10.1016/S0033-3182(80)73620-4 Ross, 1978, A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome, Am. J. Psychiatry, 1, 103 Sabelli, 1980, Tryptaldehydes (indoleacetaldehydes) in serotonergic sleep of newly hatched chicks, Arzneimittelforschung, 20, 74 Sandyk, 1985, The effect of naloxone in Tourette's syndrome, Ann. Neurol., 18, 367, 10.1002/ana.410180322 Sandyk, 1985, The opioid system in Gilles de la Tourette's syndrome, Neurology, 35, 449, 10.1212/WNL.35.3.449-b Sandyk, 1985, Transient Gilles de la Tourette syndrome following alcohol withdrawal, Br. J. Addict., 80, 213, 10.1111/j.1360-0443.1985.tb03275.x Scatton, 1982, Gamma-aminobutyric acid (GABA) receptor stimulation. IV: Effect of progabid and other GABAergic agents on acetylcholine turnover in rat brain areas, J. Pharmacol. Exp. Ther., 220, 689 Seeman, 1975, Antipsychotic drugs. Direct correlation between clinical potency and presynaptic action on dopamine nervous, Science, 188, 1217, 10.1126/science.1145194 Seifert, 1980, Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid, Ann. Neurol., 8, 38, 10.1002/ana.410080106 Seignat, 1961, Un cas de maladie de tics de Gilles da la Tourette gueri par le R-1625, Ann. Med. Psychol., 119, 578 Sethy, 1974, Regulation of striatal acetylcholine concentration by dopamine receptors, Nature, 251, 529, 10.1038/251529a0 Shapiro, 1981, The treatment of etiology of tics and Tourette syndrome, Compr. Psychiatry, 22, 193, 10.1016/0010-440X(81)90070-5 Shapiro, 1984, Controlled study of pimozide vs placebo in Tourette's syndrome, J. Am. Acad. Child. Psychiatry, 23, 161, 10.1097/00004583-198403000-00007 Shapiro, 1986, Controlled study of pimozide in 65 patients with Gilles de la Tourette's syndrome, J. Neurol. Neurosurg. Psychiatry, 49, 791, 10.1136/jnnp.49.7.791 Shapiro, 1978 Shapiro, 1983, Treatment of Gilles de la Tourette's syndrome with clonidine and neuroleptics, Arch. Gen. Psychiatry, 40, 1235, 10.1001/archpsyc.1983.01790100081011 Shapiro, 1987, Current status: Pimozide treatment of Tic and Tourette disorders, Pediatrics, 79, 1032, 10.1542/peds.79.6.1032 Shapiro, 1988 Singer, 1981, Transient Gilles de la Tourette syndrome after chronic neuroleptic withdrawal, Dev. Med. Child Neurol., 23, 518, 10.1111/j.1469-8749.1981.tb02025.x Singer, 1986, Halperidol, fluphenazine and clonidine in Tourette syndrome: Controversies in treatment, Pediatr. Neurosci., 12, 71, 10.1159/000120222 Singer, 1988, The role of “other” neuroleptic drugs in the treatment of Tourette's syndrome, 303 Singer, 1982, Clinical symptomatology, CSF neurotransmitter metabolities and serum haloperidol levels in Tourette syndrome, Adv. Neurol., 35, 177 Siomopoulos, 1974, Tardive dyskinesia. A clinical interpretation, Dis. Nerv. Syst., 35, 138 Smith, 1969, Gilles de la Tourette syndrome treated with LSD, Ir. J. Med. Soc., 2, 269, 10.1007/BF02955387 Sourkes, 1973, Enzymology and sites of action of monoamines in the central nervous system, Adv. Neurol., 2, 31 Stahl, 1980, Physostigmine in Gilles de la Tourette syndrome, N. Engl. J. Med., 302, 298, 10.1056/NEJM198001313020517 Stahl, 1981, Physostigmine in Tourette syndrome: Evidence for cholinergic underactivity, Am. J. Psychiatry, 138, 240, 10.1176/ajp.138.2.240 Sweeney, 1978, Noradrenergic and dopaminergic mechanisms in Gilles de la Tourette syndrome, Lancet, 1, 872, 10.1016/S0140-6736(78)90212-X Sweet, 1976, The pharmacology of Gilles de la Tourette's syndrome (chronic multiple tic), Clin. Neuropharmacol., 1, 81, 10.1097/00002826-197600010-00006 Sweet, 1974, Presynaptic catecholamine antagonists as treatment for Tourette syndrome: Effect of alpha-methyl-para-tyrosine and tetrabenazine, Arch. Gen. Psychiatry, 31, 857, 10.1001/archpsyc.1974.01760180095012 Sweet, 1973, Neurological features of Gilles de la Tourette's syndrome, J. Neurol. Neurosurg. Psychiatry, 36, 1, 10.1136/jnnp.36.1.1 Tolosa, 1979, Meige's disease: A clinical form of facial convulsion, bilateral and medial, Arch. Neurol., 36, 635, 10.1001/archneur.1979.00500460069010 Truitt, 1973, A biogenic amine hypothesis for alcohol tolerance, Ann. NY Acad. Sci., 215, 177, 10.1111/j.1749-6632.1973.tb28265.x Uhr, 1984, Treatment of Tourette's syndrome with RO22-1319, a D-2-receptor antagonist, N. Engl. J. Med., 311, 989, 10.1056/NEJM198410113111517 Uhr, 1986, Case report of four patients with Tourette syndrome treated with piquindone, a D2 receptor antagonist, J. Clin. Psychopharmacol., 6, 128, 10.1097/00004714-198604000-00028 Van Woert, 1976, Gilles de la Tourette syndrome: Biochemical approaches Van Woert, 1982, Overview of pharmacological approaches in therapy of Tourette syndrome, Adv. Neurol., 35, 369 Van Woert, 1975, Therapy of myoclonus with L-5-hydroxytryptophan plus MK-486, Neurology, 25, 362, 10.1212/WNL.25.2.135 Van Woert, 1975, Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor MK-486, Neurology, 25, 135, 10.1212/WNL.25.2.135 Varma, 1980, Neuroendocrine effects of lithium carbonate therapy in Gilles de la Tourette's syndrome, Res. Commun. Psychol. Psychiatr. Behav., 5, 219 Varma, 1983, Endocrine aspects of Lithium therapy in Tourette's syndrome, Brain Res. Bull., 11, 209, 10.1016/0361-9230(83)90193-4 Walsh, 1973, Biogenesis of biologically active alkaloids from amines by alcohol and acetaldehyde, Ann. NY Acad. Sci., 98, 98, 10.1111/j.1749-6632.1973.tb28255.x Woody, 1986, Tics and Tourette's syndrome: A review, J. Arkansas Med. Soc., 83, 53 Yarhura-Tobias, 1975, Chlorimipramine in Gilles de la Tourette's disease, Am. J. Psychiatr, 132, 1221, 10.1176/ajp.132.11.1221a Yarhura-Tobias, 1977, Gilles de la Tourette's syndrome: A new clinico-therapeutic approach. Progneuropsychopharmacol, Biol. Psychiatry, 1, 335 Yuonneau, 1970, Sur un cas de maladie des tics bloquee par le sulpride: Etude Psycho-biologique, Encephale, 59, 439